http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0410010-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f56142bbd7cf7a18d83f75d336f973cd
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2310-00293
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2310-00796
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-12
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-12
filingDate 1989-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4478b4e4373ac90e69fca669909377c8
publicationDate 1991-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0410010-A1
titleOfInvention Osteotropic implant material
abstract Implant material containing biocompatible ions that has the potential in aqueous solutions that the natural bone material itself has. A method for producing the implant material according to the invention is characterized in that the implant material is immersed in a dilute saline solution, a glass microelectrode is inserted into the layer after the formation of a resting layer, and a counter electrode is immersed in the saline solution for measuring the electrical potential, then if there is a deviation of the measured potential from the potential of the macerated bone, the micro / macro porosity is changed within the predetermined ranges until the potential difference becomes zero.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8163032-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10350072-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7887598-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7892291-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10376368-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0987032-A1
priorityDate 1989-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2283104-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0202908-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2548540-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0006544-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0232791-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91442
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405856
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2201750

Total number of triples: 38.